| Rx Name | MABTHERA SC 1400MG INJ (ROC) RITUXIMAB |
| Active Ingredient | RITUXIMAB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 12.5MG TAB (PFI/STO) SUNITINIB |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 25MG TAB (PFI/STO) SUNITINIB |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 50MG TAB (PFI/STO) SUNITINIB |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 12.5MG TAB (PFI) SUNITINIB (BQ) |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 25MG TAB (PFI) SUNITINIB (BQ) |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 50MG TAB (PFI) SUNITINIB (BQ) |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 12.5MG CAP (PFI) SUNITINIB |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 25MG CAP (PFI) SUNITINIB |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | SUTENT 50MG CAP (PFI) SUNITINIB |
| Active Ingredient | SUNITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | NOLVADEX -D 20MG TAB (AZN/COL) TAMOXIFEN |
| Active Ingredient | TAMOXIFEN |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | NOLVADEX -D 20MG TAB (AZN) TAMOXIFEN |
| Active Ingredient | TAMOXIFEN |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | NOLVADEX -D 20MG TAB (AZN) TAMOXIFEN |
| Active Ingredient | TAMOXIFEN |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | ACTEMRA 162MG/0.9ML INJ (ROC/AHI) TOCILIZUMAB |
| Active Ingredient | TOCILIZUMAB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | ACTEMRA 20MG/ML INJ (ROC/AHI) TOCILIZUMAB |
| Active Ingredient | TOCILIZUMAB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | ACTEMRA 20MG/ML INJ (ROC/AHI) TOCILIZUMAB |
| Active Ingredient | TOCILIZUMAB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | XELJANZ 5MG TAB (PFI/STO) TOFACITINIB |
| Active Ingredient | TOFACITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | XELJANZ 5MG TAB (PFI) TOFACITINIB (C) |
| Active Ingredient | TOFACITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | XELJANZ 5MG TAB (PFI) TOFACITINIB |
| Active Ingredient | TOFACITINIB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |
| Rx Name | HERCEPTIN 600MG SC INJ (ROC/AHI) TRASTUZUMAB |
| Active Ingredient | TRASTUZUMAB |
| Therapeutic Code | 1000 |
| Therapeutic Class | ANTINEOPLASTICS |